Harpagophytum and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Harpagophytum (devil's claw), especially for people who are female, 60+ old, also take Actemra, and have Pain.

The phase IV clinical study analyzes which people have Weakness when taking Harpagophytum. It is created by eHealthMe based on reports of 94 people who have side effects when taking Harpagophytum from the FDA, and is updated regularly.

What is Harpagophytum?

Harpagophytum has active ingredients of devil's claw. eHealthMe is studying from 95 Harpagophytum users. Check the latest studies of Harpagophytum.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 05, 2026

94 people reported to have side effects when taking Harpagophytum.
Among them, 13 people (13.83%) have Weakness.

Among these 13 people:

What is the gender of people who have Weakness when taking Harpagophytum? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Weakness when taking Harpagophytum? *

What are other drugs people take besides Harpagophytum? *

What are other side effects people have besides Weakness? *

Dizziness: 10 people, 76.92%
Nausea (feeling of having an urge to vomit): 9 people, 69.23%
Joint Swelling: 9 people, 69.23%
Weight Decreased: 7 people, 53.85%
Pain In Extremity: 6 people, 46.15%
Headache (pain in head): 6 people, 46.15%
Hand Deformity: 6 people, 46.15%
Joint Pain: 6 people, 46.15%
Finger Deformity (a deformed position of the finger): 6 people, 46.15%
Fatigue (feeling of tiredness): 6 people, 46.15%

What are the existing conditions these people have? *

Pain: 10 people, 76.92%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 69.23%
High Blood Pressure: 7 people, 53.85%
Joint Swelling: 6 people, 46.15%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 30.77%
Thyroid Diseases: 3 people, 23.08%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 23.08%
Bone Disorder: 3 people, 23.08%
Abdominal Pain Upper: 3 people, 23.08%
Inflammation: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Harpagophytum and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Harpagophytum:

Harpagophytum (95 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Harpagophytum:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on devil's claw (the active ingredients of Harpagophytum) and Harpagophytum (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.